Published on: 17 April 2015
Ms Cyntia Genolet is IFPMA’s Policy Analyst, Regulatory & Health Policy and leads the organisation’s anti-counterfeiting portfolio. In this short interview, she gives a brief summary about the threat posed by counterfeit medicines and factors encouraging the trade of counterfeit medicines.
In 2015, IFPMA is organising two workshops on counterfeit medicines in Asia and Africa.